A Trial of Lopinavir-Ritonavir in Covid-19

被引：0
|
作者：
Carmona-Bayonas, Alberto [1 ]
Jimenez-Fonseca, Paula [2 ]
Castanon, Eduardo [3 ]
机构：
[1] Hosp Univ Morales Meseguer, Murcia, Spain
[2] Hosp Univ Cent Asturias, Oviedo, Spain
[3] Clin Univ Navarra, Madrid, Spain
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis
    Deng, Jiawen
    Zhou, Fangwen
    Houl, Wenteng
    Heybati, Kiyan
    Ali, Saif
    Chang, Oswin
    Silver, Zachary
    Dhivagaran, Thanansayan
    Ramaraju, Harikrishnaa Ba
    Wong, Chi Yi
    Zuo, Qi Kang
    Lapshina, Elizabeth
    Mellett, Madeline
    FUTURE VIROLOGY, 2022, 17 (03) : 169 - 189
  • [32] Lopinavir-Ritonavir Associated Acute Kidney Injury Is Not Related to Crystalluria in Critically Ill COVID-19 Patients
    Arrestier, Romain
    Stehle, Thomas
    Letavernier, Emmanuel
    Mekontso-Dessap, Armand
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (11): : 2119 - 2119
  • [33] Hyponatraemia associated with lopinavir-ritonavir?
    Roberts, M. T. M.
    Aliyu, S. H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (01) : 83 - 84
  • [34] In severe COVID-19, adding lopinavir-ritonavir to usual care did not improve mortality at 28 days
    Singh, Ameeta
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : JC3 - JC3
  • [35] Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study
    Elmekaty, Eman Zeyad, I
    Alibrahim, Rim
    Hassanin, Rania
    Eltaib, Sitelbanat
    Elsayed, Ahmed
    Rustom, Fatima
    Ibrahim, Mohamed Izham Mohamed
    Abu Khattab, Mohammed
    Al Soub, Hussam
    Al Maslamani, Muna
    Al-Khal, Abdullatif
    PLOS ONE, 2022, 17 (05):
  • [36] Lopinavir-ritonavir alone or combined with arbidol in the treatment of 73 hospitalized patients with COVID-19: A pilot retrospective study
    Lan, Xiu
    Shao, Chuxiao
    Zeng, Xu
    Wu, Zhenbo
    Xu, Yanyan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (05) : 378 - 385
  • [37] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Antonio Vitiello
    Francesco Ferrara
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1249 - 1250
  • [38] Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
    Reactions Weekly, 2020, 1814 (1) : 9 - 9
  • [39] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [40] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
12345